An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
ConditionOverweight and Obesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age14-19
SponsorDrexel University
About this trial
The goal of this clinical trial is to learn about cardiovascular disease risk among adolescent girls with overweight/obesity. The main questions this trial aims to answer are:
1. Does an acceptance-based healthy lifestyle intervention demonstrate more weight loss than a health education intervention? 2. Does an acceptance-based healthy lifestyle intervention show more improvements in participants' physiological, health-related, and psychological factors compared to a health education intervention?
Participants in this trial will:
1. Engage in treatment for 6-months, comprising of a mixture of in-person and remote group sessions, occurring at Drexel University or over a video-conferencing platform. 2. Complete various assessments. These include self-reported questionnaires, measures of weight, height, body composition, blood pressure, and blood lipids, and wearing of smart watches to measure sleep and physical activity.
Researchers will compare the acceptance-based and health education intervention groups to see if the acceptance-based treatment will indeed be effective in improving participants' health outcomes.
Eligibility criteria
Qualifiers
Ages 14-19
Gender identification as girl
BMI percentile ≥ 85th percentile for sex-and-age
Disqualifiers
Experience of weight loss of ≥5% of body weight in the past 6 months for any reason except post-partum weight loss
Having recently begun or changed the dosage of any medication known to affect appetite or body composition within the last 3 months
Plans to move out of the area within the next year
Active cancer or cancer requiring treatment in the past 2 years (except non-melanoma skin cancer)
Trial design
Treatments tested in this trial
- Acceptance-based Treatment (ABT)
- Health Education (HE) Comparison
Treatment groups
148 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov